Skip to main content

Online Exclusive

Melissa Weiss, Associate Editor
A poster study, presented at the 2019 American Academy of Dermatology Annual Meeting, highlighted the long-term safety of the first new clinical treatment for hyperhidrosis since the approval of Botox 15 years ago. David M. Pariser, MD, lead study author, discussed the study results in an interview with The Dermatologist.
Luke C. Olson, MD; Michelle Henry, MD; and Cynthia M. Magro, MD
A 45-year-old man presented to dermatology with a long-standing subcentimeter nodule on the right inferior central malar cheek. A shave biopsy showed an extensive tumefactive atypical glandular proliferation primarily involving the dermis throughout its depth.
Melissa Weiss, Associate Editor
A poster study showed patients with hidradenitis suppurativa are comfortable discussing sexual health concerns with dermatologists. Andrea Murina, MD, corresponding author of the study, discusses the results and how dermatologists can improve patients’ comfort levels during clinical exams.
Kristi Hawley, DO, FAAD
Prior authorizations (PA) were intended to improve patient care. In this commentary, Kristi Hawley, DO, outlines the burden of PAs on physicians and patients.
Melissa Weiss, Associate Editor
Results from a recent study suggest apremilast may effectively treat bothersome symptoms of scalp psoriasis. Dr Linda Stein Gold, with Henry Ford Health System, discusses these results with The Dermatologist.
New products include Ceramax new skin barrier lotion and cream, an acne care system, eco-friendly sunscreen, and more.
Michael Heath and Steven R. Feldman, MD, PhD
This 4 part series discusses various approaches to improve patient adherence.
Melissa Weiss, Associate Editor
​​​​​​​More than 90 sessions were presented at this year’s American Academy of Dermatology (AAD) summer meeting at the Hyatt Regency in Chicago, IL.
Robin Ntoh
Dermatologists are adopting new reporting and analytics solutions to help grow their practices.
Back to Top